Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C9H14F2N3O13P3 |
| Molecular Weight | 503.1379 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C2(F)F
InChI
InChIKey=YMOXEIOKAJSRQX-QPPQHZFASA-N
InChI=1S/C9H14F2N3O13P3/c10-9(11)6(15)4(25-7(9)14-2-1-5(12)13-8(14)16)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h1-2,4,6-7,15H,3H2,(H,20,21)(H,22,23)(H2,12,13,16)(H2,17,18,19)/t4-,6-,7-/m1/s1
| Molecular Formula | C9H14F2N3O13P3 |
| Molecular Weight | 503.1379 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells. | 2010-08-19 |
|
| Prolonged versus standard gemcitabine infusion: translation of molecular pharmacology to new treatment strategy. | 2008-03 |
|
| Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors. | 2006-05 |
|
| Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase. | 2003-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:43:12 GMT 2025
by
admin
on
Mon Mar 31 22:43:12 GMT 2025
|
| Record UNII |
A0Q7SO4OZE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80911928
Created by
admin on Mon Mar 31 22:43:12 GMT 2025 , Edited by admin on Mon Mar 31 22:43:12 GMT 2025
|
PRIMARY | |||
|
110988-86-8
Created by
admin on Mon Mar 31 22:43:12 GMT 2025 , Edited by admin on Mon Mar 31 22:43:12 GMT 2025
|
PRIMARY | |||
|
A0Q7SO4OZE
Created by
admin on Mon Mar 31 22:43:12 GMT 2025 , Edited by admin on Mon Mar 31 22:43:12 GMT 2025
|
PRIMARY | |||
|
130659
Created by
admin on Mon Mar 31 22:43:12 GMT 2025 , Edited by admin on Mon Mar 31 22:43:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> METABOLITE ACTIVE |
|
||
|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|